TEDA Biomedical Shareholders Authorise Board to Issue Up to 50% Additional Equity

Bulletin Express
Sep 24

Tianjin TEDA Biomedical Engineering Company Limited (TEDA Biomedical) reported that shareholders approved a key special resolution at the 24 September 2026 Extraordinary General Meeting (EGM), granting the Board discretionary authority to issue new shares representing up to 50% of the company’s existing issued share capital within the next three years.

The proposal was carried by poll, receiving 482.72 million votes in favour (72.57%) against 182.50 million votes (27.43%), out of a total 665.22 million shares voted. Voter turnout stood at roughly 31.2% of TEDA Biomedical’s 2.13 billion issued shares.

Under the newly added Articles of Association clauses, the Board may execute equity issuances without further shareholder approval unless the consideration involves non-monetary assets, in which case a separate shareholder resolution is required. Any Board decision under this mandate must secure support from at least two-thirds of all directors and comply with listing-venue securities regulations.

No shareholders were obliged to abstain, and none indicated an intention to vote against or abstain prior to the meeting. All resolutions in the EGM notice dated 7 September 2026 were passed.

Executive Director Yang Zeng, Non-Executive Directors Xia Alan Zhe and Wang Lei, and Independent Non-Executive Directors Tu Xiangzhen and Chen Jiang attended the meeting. Peking Certified Public Accountants served as the independent scrutineer for the vote count.

TEDA Biomedical’s announcement will remain available on the Hong Kong Stock Exchange and company websites for seven days from posting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10